- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Factor VIII antigen
Total 38085 results
-
McMaster UniversityCanadian Hemophilia SocietyCompletedHemophilia A | Hemophilia BCanada
-
National Cancer Institute, EgyptCompletedProstate Cancer MetastaticEgypt
-
Boston VA Research Institute, Inc.University of Michigan; Emory University; ShireWithdrawn
-
OctapharmaTerminated
-
Hasan Kalyoncu UniversityUnknown
-
Sohag UniversityUnknownImmunological Testing in Small-vessel VasculitisJapan
-
OctapharmaCompletedSevere Hemophilia ACanada, United States, France, Spain, Ukraine, United Kingdom, Belarus, Georgia, Germany, India, Italy, Moldova, Republic of, Morocco, Poland, Portugal, Russian Federation, Slovenia
-
OctapharmaCompletedSevere Hemophilia ABulgaria, Poland, Hungary, Romania, Russian Federation
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia AUnited States, United Kingdom, Spain, Hong Kong, Israel, New Zealand, Sweden, Australia, Brazil, Japan, Austria, Belgium, Italy, India, Switzerland, Canada, France, Germany, South Africa
-
Children's Mercy Hospital Kansas CityTerminatedHemophilia A | Hemophilia B | Hemophilia | Factor IX Deficiency | Factor VIII DeficiencyUnited States
-
PfizerTerminatedStaphylococcal VaccineUnited States, Spain, United Kingdom, Canada, France, Japan, Germany, Hungary, Austria, Bulgaria, Sweden
-
Bioverativ Therapeutics Inc.CompletedHemophilia AUnited States, Canada, Italy, Australia, Austria, Belgium, Brazil, France, Germany, Hong Kong, India, Ireland, Israel, Japan, Netherlands, New Zealand, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia AUnited States, Hong Kong, Israel
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia AUnited States, United Kingdom, Australia
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia AUnited States, Australia, New Zealand
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedHemophilia AUnited States, Poland, United Kingdom, Netherlands, South Africa, Hong Kong, Australia, Ireland
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumTerminatedHemophilia A | Hemophilia BUnited States
-
Kenya Medical Research InstituteFoundation for Innovative New Diagnostics (FIND)Unknown
-
City of Hope Medical CenterCSL Behring; Grifols Therapeutics LLC; Grifols Biologicals, LLC; Charta Foundation and other collaboratorsWithdrawn
-
Immetacyte LtdWithdrawnOvarian Cancer MetastaticUnited Kingdom
-
PfizerWithdrawn
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Kang YUCARsgen Therapeutics Co., Ltd.Active, not recruitingHepatocellular Carcinoma | B Cell Lymphoma | Pancreatic Carcinoma | Myeloma | B Cell Leukemia | Adenocarcinoma of Esophagogastric JunctionChina
-
The Hospital for Sick ChildrenCompleted
-
The Second Hospital of Shandong UniversityShandong Sunstem Biotechnology Co.,Ltd.Unknown
-
National Cancer Institute (NCI)CompletedNeoplasms | Breast Cancer | Lung Cancer | Prostate Cancer | Colon CancerUnited States
-
Hoffmann-La RocheCompletedPediatric Immuno-Tolerant Chronic Hepatitis BUnited States, Belgium, Australia, Germany, Italy, Malaysia, Romania, Russian Federation, Taiwan, Turkey, Ukraine, United Kingdom
-
BayerCompletedHemophilia ABelgium, New Zealand, Netherlands, Greece, United Kingdom, Austria, United States, Italy, Romania, Bulgaria, Canada, Israel, Poland, Lithuania, Norway, Argentina, Spain
-
Jonsson Comprehensive Cancer CenterPfizerCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AChina
-
Oregon Health and Science UniversityCompleted
-
Biomedical Advanced Research and Development AuthorityCompletedInfluenza A Virus, H5N1 SubtypeUnited States
-
PTC TherapeuticsGenzyme, a Sanofi CompanyTerminatedHemophilia A | Hemophilia BUnited States, Canada, France, Italy
-
University of California, DavisTerminatedHemophilia A | Hemophilia A With InhibitorUnited States
-
Zagazig UniversityCompleted
-
AbbVieEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedGlioblastomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Singapore, Spain, Switzerland, Taiwan, United Kingdom
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy
-
Baylor College of MedicineThe Methodist Hospital Research InstituteWithdrawn
-
Assiut UniversityCompletedRheumatoid ArthritisEgypt
-
Victor BlanchetteQueen's University; Sydney Children's Hospitals Network; Royal Children's Hospital and other collaboratorsUnknown
-
Kaifeng Pharmaceutical (Group) Co., Ltd.Beijing Furen Biomedical Research Institute Co., Ltd.Unknown
-
National Institute of Diabetes and Digestive and...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedType 1 Diabetes MellitusUnited States, Canada
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedCat Allergy | Cat HypersensitivityUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AIndia
-
Christopher Bowlus, MDBristol-Myers SquibbCompletedPrimary Biliary CirrhosisUnited States